Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
1.610
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Incannex Healthcare Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2016 |
| Operating Revenue | 0.1 | 0.01 | - | - | 1.9 | 0.6 | Upgrade
|
| Other Revenue | - | - | - | 0.78 | 0 | - | Upgrade
|
| Revenue | 0.1 | 0.01 | - | 0.78 | 1.9 | 0.6 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -58.77% | 213.71% | 38849.39% | Upgrade
|
| Cost of Revenue | - | - | - | 0.01 | 0.91 | 0.45 | Upgrade
|
| Gross Profit | 0.1 | 0.01 | - | 0.78 | 0.99 | 0.15 | Upgrade
|
| Selling, General & Admin | 16.58 | 17.17 | 8.01 | 5.16 | 5.86 | 1.39 | Upgrade
|
| Research & Development | 5.57 | 1.45 | 5.63 | 5.37 | 4.75 | 2.11 | Upgrade
|
| Other Operating Expenses | - | - | - | - | -0.04 | -0.12 | Upgrade
|
| Operating Expenses | 22.14 | 18.62 | 13.64 | 12.13 | 11.17 | 3.94 | Upgrade
|
| Operating Income | -22.05 | -18.61 | -13.64 | -11.35 | -10.19 | -3.79 | Upgrade
|
| Interest Expense | -0.17 | - | - | - | - | - | Upgrade
|
| Interest & Investment Income | 0.17 | 0.21 | 0.24 | 0.01 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.35 | -0.03 | -0.07 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -1.38 | - | - | -3.56 | -1.19 | -0.24 | Upgrade
|
| EBT Excluding Unusual Items | -23.77 | -18.43 | -13.46 | -14.9 | -11.37 | -4.02 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.09 | Upgrade
|
| Pretax Income | -23.77 | -18.43 | -48.81 | -14.9 | -11.37 | -3.93 | Upgrade
|
| Income Tax Expense | 0.03 | 0.03 | - | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -23.8 | -18.46 | -48.81 | -14.9 | -11.37 | -3.93 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -0.77 | Upgrade
|
| Net Income | -23.8 | -18.46 | -48.81 | -14.9 | -11.37 | -4.7 | Upgrade
|
| Net Income to Common | -23.8 | -18.46 | -48.81 | -14.9 | -11.37 | -4.7 | Upgrade
|
| Shares Outstanding (Basic) | 17 | 16 | 15 | 298 | 244 | 171 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 16 | 15 | 298 | 244 | 171 | Upgrade
|
| Shares Change (YoY) | 7.18% | 5.07% | -94.83% | 21.93% | 42.82% | 52.88% | Upgrade
|
| EPS (Basic) | -1.40 | -1.14 | -3.17 | -0.05 | -0.05 | -0.03 | Upgrade
|
| EPS (Diluted) | -1.40 | -1.14 | -3.17 | -0.05 | -0.05 | -0.03 | Upgrade
|
| Free Cash Flow | -15.87 | -16.12 | -11.07 | -12.81 | -6.91 | -3.91 | Upgrade
|
| Free Cash Flow Per Share | -0.93 | -1.00 | -0.72 | -0.04 | -0.03 | -0.02 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | - | 99.19% | 51.94% | 25.55% | Upgrade
|
| Operating Margin | -22495.92% | -155058.33% | - | -1450.78% | -536.77% | -626.26% | Upgrade
|
| Profit Margin | -24289.80% | -153825.00% | - | -1904.94% | -599.33% | -776.62% | Upgrade
|
| Free Cash Flow Margin | -16193.88% | -134350.00% | - | -1636.97% | -364.13% | -645.96% | Upgrade
|
| EBITDA | -21.78 | -18.5 | -13.62 | - | - | -3.75 | Upgrade
|
| D&A For EBITDA | 0.27 | 0.1 | 0.02 | - | - | 0.04 | Upgrade
|
| EBIT | -22.05 | -18.61 | -13.64 | -11.35 | -10.19 | -3.79 | Upgrade
|
| Revenue as Reported | - | - | - | - | 1.97 | 0.82 | Upgrade
|
| Advertising Expenses | - | - | - | 2.75 | 4.35 | 0.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.